BioSpace News Archive

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today provided a business update for the first quarter ended March 31, 2022 and reported on recent corporate developments and upcoming milestones.

The Neonatal Intensive Care Unit (NICU) Catheters Market was valued at US$ 343.91 million in 2021 and is projected to surpass US$ 560.06 million by 2030 with a CAGR of 5.6% from 2022 to 2030.

The cell and tissue preservation market was valued at US$ 3.56 billion in 2021 and is estimated to worth around US$ 8.52 billion by 2029 with a CAGR of 11.6% from 2022 to 2030.

Ten biotech advancements from Mass General Brigham have been awarded Innovation Discovery Grants in the 2022 round of awards for the highly competitive grant program.

Cadence, Inc., a leading contract manufacturer of medical and drug delivery devices, is pleased to announce the appointment of Rob Werge as its new President and Chief Executive Officer.

Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor inhibitor (ARi) NUBEQA ® .

Alpine Immune Sciences, Inc. announced that members of its management team will participate at the following investor conferences in May 2022: LifeSci Partners Immunology & Inflammation Symposium Date: Tuesday, May 10, 2022 Time: 3:00 p.m. ET/12:00 p.m.

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.

CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time.

Capricor Therapeutics will release its financial results for the first quarter ended March 31, 2022, after the market close on Tuesday, May 10, 2022.